IRIS
CAMPIANI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.665
EU - Europa 13.026
AS - Asia 1.942
OC - Oceania 27
AF - Africa 23
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 13
Totale 30.715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.605
GB - Regno Unito 4.104
IE - Irlanda 2.422
IT - Italia 1.724
CN - Cina 1.630
SE - Svezia 1.226
UA - Ucraina 1.221
DE - Germania 890
FR - Francia 699
FI - Finlandia 406
TR - Turchia 150
ES - Italia 90
CA - Canada 57
BE - Belgio 46
IN - India 44
AT - Austria 33
RU - Federazione Russa 31
GR - Grecia 26
VN - Vietnam 26
RO - Romania 25
AU - Australia 22
NL - Olanda 22
IR - Iran 21
EU - Europa 12
JP - Giappone 12
PL - Polonia 11
PT - Portogallo 10
SG - Singapore 9
BR - Brasile 8
ID - Indonesia 8
NG - Nigeria 8
EG - Egitto 7
KR - Corea 7
CL - Cile 6
HU - Ungheria 6
BG - Bulgaria 5
LA - Repubblica Popolare Democratica del Laos 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
IL - Israele 4
CH - Svizzera 3
DK - Danimarca 3
HK - Hong Kong 3
KW - Kuwait 3
NO - Norvegia 3
PA - Panama 3
PK - Pakistan 3
RS - Serbia 3
AZ - Azerbaigian 2
EE - Estonia 2
HR - Croazia 2
IM - Isola di Man 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BO - Bolivia 1
CO - Colombia 1
GH - Ghana 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MD - Moldavia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VE - Venezuela 1
Totale 30.715
Salva come PNG Salva come JPEG
Città #
Southend 3.822
Fairfield 2.762
Dublin 2.402
Ashburn 1.472
Chandler 1.308
Woodbridge 1.196
Jacksonville 1.006
Seattle 984
Wilmington 979
Cambridge 926
Houston 909
Siena 710
Ann Arbor 654
Princeton 396
Beijing 375
Nanjing 344
Boardman 166
Dearborn 164
Fremont 156
Helsinki 153
New York 143
San Diego 136
Izmir 134
Shanghai 132
Nanchang 127
Florence 95
San Mateo 90
Washington 81
Málaga 79
Menlo Park 77
Shenyang 69
Hebei 68
Lappeenranta 65
Jiaxing 57
Kunming 57
Venezia 55
Lancaster 54
Redwood City 51
Düsseldorf 46
Brussels 44
Milan 43
Tianjin 43
London 42
Ningbo 41
Changsha 40
Jinan 40
Norwalk 39
Rome 38
Aachen 34
Guangzhou 30
Vienna 26
Ottawa 24
Dong Ket 23
Hangzhou 22
Hanover 22
San Francisco 20
Philadelphia 19
Hefei 18
Toronto 18
Zhengzhou 17
Los Angeles 15
Timisoara 15
Avellino 14
Taizhou 14
Parma 13
Salerno 13
Marietta 12
Rende 12
San Giovanni Valdarno 12
Changchun 11
Frankfurt am Main 11
Naples 11
Palermo 11
Pisa 11
Lanzhou 10
Leawood 10
Prato 10
Arezzo 9
Haikou 9
Maletto 9
Mestre 9
Amsterdam 8
Borgo San Lorenzo 8
Catanzaro 8
Kilburn 8
Lagos 8
Palo Alto 8
Ventimiglia 8
Bari 7
Bologna 7
Hounslow 7
Lanuvio 7
Tokyo 7
Turin 7
Andover 6
Catania 6
Edinburgh 6
Las Vegas 6
Melbourne 6
Mumbai 6
Totale 23.518
Salva come PNG Salva come JPEG
Nome #
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 280
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents 262
Development of novel cyclic peptides as pro-apoptotic agents 252
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]- N -[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues 246
(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: further exploration of bioisosteric replacements and structural and biological investigation 241
iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated α-tubulin defect which improves after iHDAC6 treatment in Rett syndrome 236
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 235
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies 218
The 1-(2,3-dichlorophenyl)-piperazine-to-aripiprazole ratio at steady state in rats and schizophrenic patients 212
A new microtubule-targeting compound PBOX-15 inhibits T-cell migration via post-translational modifications of tubulin 211
Synthetic spirocyclic endoperoxides: new antimalarial scaffolds 211
First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents 206
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases 206
Synthesis, Molecular Modelling and Biological Studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors 204
Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II) 203
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 201
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 199
Natural Compounds and Synthetic Drugs to Target FAAH Enzyme 199
null 195
Identification of novel fluorescent probes preventing PrP(Sc) replication in prion diseases 192
Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies 192
Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking 187
A Jocic-type approach for a practical and scalable synthesis of pyrrolonaphthoxazepine (PNOX)-based potent proapoptotic agents 185
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 184
Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors 180
Structural characterization of Giardia duodenalis thioredoxin reductase (gTrxR) and computational analysis of its interaction with NBDHEX 180
Selective Kainate Receptor (GluK1) Ligands Structurally Based upon 1H-Cyclopentapyrimidin-2,4(1H,3H)-dione: Synthesis, Molecular Modeling, and Pharmacological and Biostructural Characterization 179
Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase 175
Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine d3 and serotonin 5-HT 1A and 5-HT2A receptors: Design, synthesis, and effects on behavior 174
A stereoselective route to 6-substituted pyrrolo-1,5-benzoxazepinones and their analogues 171
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold 169
Synthetic studies toward 1,2-dioxanes as precursors of potential endoperoxide-containing antimalarials 168
1H-Cyclopentapyrimidine-2,4(1H,3H)-dione-Related Ionotropic Glutamate Receptors Ligands. Structure-Activity Relationships and Identification of Potent and Selective iGluR5 Modulators 167
Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease 167
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity 167
Optimization of 4-Aminoquinoline/Clotrimazole-Based Hybrid Antimalarials: Further Structure-Activity Relationships, in vivo Studies, and Preliminary Toxicity Profiling 165
Pyrrolo 1,3 benzothiazepine-based Atypical Antipsychotic Agents. Synthesis, Structure-Activity Relationship, Molecular Modeling, and Biological Studies 163
Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases 163
Non-Nucleoside Inhibitors of Human Adenosine Kinase: Synthesis, Molecular Modeling, and Biological Studies 160
Novel Ligands Specific for Mitochondrial Benzodiazepine Receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine Derivatives. Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies 159
Synthesis and Antiplasmodial Activity of Bicyclic Dioxanes as Simplified Dihydroplakortin Analogues 158
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 158
Synthesis of Dihydroplakortin, 6-epi-Dihydroplakortin, and Their C10-Desethyl Analogues 157
Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as Potential Antimalarial Agents 157
Cardiovascular Characterization of Pyrrolo[2,1-d][1,5]benzothiazepine Derivatives Binding Selectively to the Peripheral-Type Benzodiazepine Receptor (PBR):  From Dual PBR Affinity and Calcium Antagonist Activity to Novel and Selective Calcium Entry Blockers 157
A light in the dark: State of the art and perspectives in optogenetics and optopharmacology for restoring vision 157
Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds 157
Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors 156
Microwave-assisted synthesis of 4-quinolylhydrazines followed by nickel boride reduction: a convenient approach to 4-aminoquinolines and derivatives 156
A synthetic strategy to bridged 2,3,8-trioxabicyclo[3,3,1]nonane endoperoxides 155
Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials 155
Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1 154
Synthetic studies toward bicyclic endoperoxides presenting polar side chains 154
Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D-3 and Serotonin 5-HT1A and 5-HT2A Receptors 154
Pyrroloquinoxaline Derivatives as High-Affinity and Selective 5-HT3 Receptor Agonists: Synthesis, Further Structure-Activity Relationships, and Biological Studies 153
Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation 153
A stereoselective approach to peptidomimetic BACE1 inhibitors 152
Unravelling the response of chronic lymphocytic leukemia to a novel class of anticancer agents, the pyrrolonaphthoxazepines (PNOXs) 151
Pyrrolo[2,1-c][1,4]benzothiazines: Synthesis, Structure-Activity Relationships, Molecular Modeling Studies, and Cardiovascular Activity 150
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats 149
Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore. 149
Development of a multiplexed activity-based protein profiling assay to evaluate activity of endocannabinoid hydrolase inhibitors 149
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation 148
Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains. 147
Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model 147
Development of Antitubercular Compounds Based on a 4-Quinolylhydrazone Scaffold. Further Structure-activity Relationship Studies. 146
Dopamine D3 receptor antagonists as potential therapeutics for the treatment of neurological diseases 146
ARYL PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROPSYCHIATRY DISORDERS. 145
Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling. 145
ANTIMALARIAL AGENTS HAVING POLYAROMATIC STRUCTURE 143
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents. 141
New Antipsychotic Agents with Serotonin and Dopamine Antagonist Properties Based on a Pyrrolo[2,1-b][1,3]benzothiazepine Structure 141
A Comparative Molecular Field Analysis Model for 6-Arylpyrrolo[2,1-d][1,5]benzothiazepines Binding Selectively to the Mitochondrial Benzodiazepine Receptor 141
Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors 141
A Concerted Study Using Binding Measurements, X-ray Structural Data, and Molecular Modeling on the Stereochemical Features Responsible for the Affinity of 6-Arylpyrrolo[2,1-d][1,5]benzothiazepines toward Mitochondrial Benzodiazepine Receptors 141
A palladium-catalyzed synthetic approach to new Huperzine A analogues modified at the pyridone ring 140
Novel peptidomimetics as BACE-1 inhibitors: synthesis, molecular modeling, and biological studies 140
Pyrrolobenzoxazepinone Derivatives as Non-Nucleoside HIV-1 RT Inhibitors: Further Structure-Activity Relationship Studies and Identification of More Potent Broad-Spectrum HIV-1 RT Inhibitors with Antiviral Activity 139
Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent 139
Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils 138
Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation 138
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors. 138
Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders 137
Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target 135
Novel aryl piperazine derivatives with medical utility 134
Malaria chemotherapy: recent advances in drug development 134
An approach to modified heterocyclic analogues of huperzine A and isohuperzine A. Synthesis of the pyrimidone and pyrazole analogues, and their anticholinesterase activity 134
Synthesis and preliminary biological evaluation of 1-aminomethyl-4-substituted-4-H-pyrrolo[2,1-C][1,4] benzothiazines, a new class of calcium antagonists 133
Polycondensed heterocycles. IV. Synthesis of 1,4-Dioxo-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzothiazine 133
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 132
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties 131
Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines 131
Synthesis and “in vitro” cardiovascular activity of 4-aryl-2,3,3a,4-tetrahydro-1h-pyrrolo[2,1-c][1,4]benzothiazin-1-ones and 7-acetoxy-6-phenyl-7a,8,9,10-tetrahydropyrrolo [2,1,-d][1,5]benzothiazepin-10-one 131
Synthesis, Biological Activity, and SARs of Pyrrolobenzoxazepine Derivatives, a New Class of Specific “Peripheral-Type” Benzodiazepine Receptor Ligands 131
Specific Targeting of Hepatitis C Virus NS3 RNA Helicase. Discovery of the Potent and Selective Competitive Nucleotide-Mimicking Inhibitor QU663 130
Polycondensed heterocycles. V. Synthesis of 5H,11H-Pyrrolo[2,1-c][1,4]benzothiazepine 130
A Straightforward Approach for Engineering Efficacy and Selectivity at GPCRs 130
Pyrrolobenzothiazepinones and Pyrrolobenzoxazepinones:  Novel and Specific Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors with Antiviral Activity 130
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 129
An efficient approach to D-threo-3-hydroxyaspartic acid for the synthesis of novel L-threo-oxazolines as selective blockers of glutamate reversed uptake 129
Totale 16.473
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.987 0 0 0 0 0 0 0 0 0 0 1.084 903
2019/20206.727 795 255 416 1.093 456 603 612 801 553 572 163 408
2020/20215.596 239 500 254 515 364 874 383 693 516 557 440 261
2021/20223.544 302 526 243 194 174 82 200 140 170 437 390 686
2022/20235.014 298 413 670 707 553 1.004 120 399 452 139 163 96
2023/20243.774 170 90 376 193 222 1.139 1.306 78 36 139 25 0
Totale 31.255